MLC Stock Overview
Through its subsidiaries, operates in the life sciences industry in Ireland and the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Malin Corporation plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €6.05 |
| 52 Week High | €6.50 |
| 52 Week Low | €4.10 |
| Beta | 0.90 |
| 11 Month Change | 0.83% |
| 3 Month Change | 1.68% |
| 1 Year Change | 37.50% |
| 33 Year Change | -9.02% |
| 5 Year Change | 54.34% |
| Change since IPO | -43.83% |
Recent News & Updates
Recent updates
Shareholder Returns
| MLC | IE Life Sciences | IE Market | |
|---|---|---|---|
| 7D | 0% | -6.0% | -0.5% |
| 1Y | 37.5% | 1.4% | 8.7% |
Return vs Industry: MLC exceeded the Irish Life Sciences industry which returned 1.6% over the past year.
Return vs Market: MLC exceeded the Irish Market which returned 9.7% over the past year.
Price Volatility
| MLC volatility | |
|---|---|
| MLC Average Weekly Movement | 6.0% |
| Life Sciences Industry Average Movement | 6.2% |
| Market Average Movement | 3.8% |
| 10% most volatile stocks in IE Market | 6.1% |
| 10% least volatile stocks in IE Market | 2.4% |
Stable Share Price: MLC's share price has been volatile over the past 3 months compared to the Irish market.
Volatility Over Time: MLC's weekly volatility (6%) has been stable over the past year, but is still higher than 75% of Irish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | 3 | n/a | www.malinplc.com |
Malin Corporation plc, through its subsidiaries, operates in the life sciences industry in Ireland and the United States. It also provides company secretarial services and engages in investment activities. The company was incorporated in 2014 and is headquartered in Dublin, Ireland.
Malin Corporation plc Fundamentals Summary
| MLC fundamental statistics | |
|---|---|
| Market cap | €114.28m |
| Earnings (TTM) | -€1.10m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-103.9x
P/E RatioIs MLC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MLC income statement (TTM) | |
|---|---|
| Revenue | €0 |
| Cost of Revenue | €0 |
| Gross Profit | €0 |
| Other Expenses | €1.10m |
| Earnings | -€1.10m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.058 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0% |
How did MLC perform over the long term?
See historical performance and comparison